Medicine and Dentistry
Pruritus
56%
Bullous Pemphigoid
50%
Immunoglobulin E
50%
Autoantibodies
50%
microRNA
50%
Rectum Cancer
50%
Colorectal Carcinoma
20%
Disease
12%
Atopic Dermatitis
10%
Clinical Trial
10%
Dermis
10%
Cancer Growth
10%
Colon Adenocarcinoma
10%
The Cancer Genome Atlas
10%
Neoplasm
10%
Dermatosis
7%
Eosinophil
7%
Blister
6%
Pemphigus
6%
Enzyme Linked Immunosorbent Assay
6%
Granulocyte
5%
Dupilumab
5%
Systemic Disease
5%
Dermatitis
5%
Histamine H4 Receptor
5%
Nemolizumab
5%
Receptor Antagonist
5%
Neuromodulation
5%
Colon Tissue
5%
Malignant Neoplasm
5%
Gene Expression
5%
Protective Factor
5%
Biological Marker
5%
Proportional Hazards Model
5%
Adverse Outcome
5%
Cancer
5%
Genetic Predisposition
5%
Tumor Progression
5%
Disease Exacerbation
5%
Tumor Cell
5%
Immunology and Microbiology
Bullous Pemphigoid
100%
Autoantibodies
66%
Atopic Dermatitis
50%
Immunoglobulin E
50%
Eosinophil Granulocyte
27%
Dermatitis
25%
Dupilumab
25%
Nemolizumab
25%
Neuromodulation
25%
Pemphigoid
21%
Hemidesmosome
16%
Liquid
16%
Immunology
16%
Autoimmune Skin Disease
16%
Dermis
16%
Pemphigus
6%
Pharmacology, Toxicology and Pharmaceutical Science
Pruritus
50%
Atopic Dermatitis
10%
Clinical Trial
10%
Disease
5%
Receptor Antagonist
5%
Inflammation
5%
Systemic Disease
5%
Dermatitis
5%
Nemolizumab
5%
Histamine H4 Receptor
5%
Dupilumab
5%
Skin Disease
5%
